Cargando…

Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca(2+) channels

OBJECTIVE: To determine whether immunoglobulin G (IgG) from patients with Lambert-Eaton myasthenic syndrome (LEMS) decreases action potential–evoked synaptic vesicle exocytosis, and whether the effect is mediated by P/Q-type voltage-gated calcium channels (VGCCs). METHODS: IgG was obtained from 4 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Spillane, Jennifer, Ermolyuk, Yaroslav, Cano-Jaimez, Marife, Lang, Bethan, Vincent, Angela, Volynski, Kirill E., Kullmann, Dimitri M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335987/
https://www.ncbi.nlm.nih.gov/pubmed/25589670
http://dx.doi.org/10.1212/WNL.0000000000001225
_version_ 1782358416968122368
author Spillane, Jennifer
Ermolyuk, Yaroslav
Cano-Jaimez, Marife
Lang, Bethan
Vincent, Angela
Volynski, Kirill E.
Kullmann, Dimitri M.
author_facet Spillane, Jennifer
Ermolyuk, Yaroslav
Cano-Jaimez, Marife
Lang, Bethan
Vincent, Angela
Volynski, Kirill E.
Kullmann, Dimitri M.
author_sort Spillane, Jennifer
collection PubMed
description OBJECTIVE: To determine whether immunoglobulin G (IgG) from patients with Lambert-Eaton myasthenic syndrome (LEMS) decreases action potential–evoked synaptic vesicle exocytosis, and whether the effect is mediated by P/Q-type voltage-gated calcium channels (VGCCs). METHODS: IgG was obtained from 4 patients with LEMS (3 males, 1 female), including 2 patients with lung malignancy. Antibodies against P/Q-type VGCCs were detected in all 4 patients, and against N-type VGCCs in 2. We incubated neuronal cultures with LEMS IgG and determined the size of the total recycling pool of synaptic vesicles and the rate of action potential–evoked exocytosis using fluorescence imaging of the amphiphilic dye SynaptoRed C1. Pooled IgG from healthy volunteers was used as a control. We repeated the experiments on synapses lacking P/Q-type calcium channels from a Cacna1a knockout mouse to determine whether these channels account for the pathogenic effect of LEMS IgG. RESULTS: LEMS IgG had no effect on the total recycling pool size but significantly reduced the rate of action potential–evoked synaptic exocytosis in wild-type neurons when compared with neurons treated with control IgG. In contrast, LEMS IgG had no effect on the rate of synaptic vesicle exocytosis in neurons lacking P/Q-type channels. CONCLUSIONS: These data provide direct evidence that LEMS IgG inhibits neurotransmitter release by acting on P/Q-type VGCCs.
format Online
Article
Text
id pubmed-4335987
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-43359872015-02-25 Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca(2+) channels Spillane, Jennifer Ermolyuk, Yaroslav Cano-Jaimez, Marife Lang, Bethan Vincent, Angela Volynski, Kirill E. Kullmann, Dimitri M. Neurology Article OBJECTIVE: To determine whether immunoglobulin G (IgG) from patients with Lambert-Eaton myasthenic syndrome (LEMS) decreases action potential–evoked synaptic vesicle exocytosis, and whether the effect is mediated by P/Q-type voltage-gated calcium channels (VGCCs). METHODS: IgG was obtained from 4 patients with LEMS (3 males, 1 female), including 2 patients with lung malignancy. Antibodies against P/Q-type VGCCs were detected in all 4 patients, and against N-type VGCCs in 2. We incubated neuronal cultures with LEMS IgG and determined the size of the total recycling pool of synaptic vesicles and the rate of action potential–evoked exocytosis using fluorescence imaging of the amphiphilic dye SynaptoRed C1. Pooled IgG from healthy volunteers was used as a control. We repeated the experiments on synapses lacking P/Q-type calcium channels from a Cacna1a knockout mouse to determine whether these channels account for the pathogenic effect of LEMS IgG. RESULTS: LEMS IgG had no effect on the total recycling pool size but significantly reduced the rate of action potential–evoked synaptic exocytosis in wild-type neurons when compared with neurons treated with control IgG. In contrast, LEMS IgG had no effect on the rate of synaptic vesicle exocytosis in neurons lacking P/Q-type channels. CONCLUSIONS: These data provide direct evidence that LEMS IgG inhibits neurotransmitter release by acting on P/Q-type VGCCs. Lippincott Williams & Wilkins 2015-02-10 /pmc/articles/PMC4335987/ /pubmed/25589670 http://dx.doi.org/10.1212/WNL.0000000000001225 Text en © 2015 American Academy of Neurology This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Spillane, Jennifer
Ermolyuk, Yaroslav
Cano-Jaimez, Marife
Lang, Bethan
Vincent, Angela
Volynski, Kirill E.
Kullmann, Dimitri M.
Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca(2+) channels
title Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca(2+) channels
title_full Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca(2+) channels
title_fullStr Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca(2+) channels
title_full_unstemmed Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca(2+) channels
title_short Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca(2+) channels
title_sort lambert-eaton syndrome igg inhibits transmitter release via p/q ca(2+) channels
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335987/
https://www.ncbi.nlm.nih.gov/pubmed/25589670
http://dx.doi.org/10.1212/WNL.0000000000001225
work_keys_str_mv AT spillanejennifer lamberteatonsyndromeigginhibitstransmitterreleaseviapqca2channels
AT ermolyukyaroslav lamberteatonsyndromeigginhibitstransmitterreleaseviapqca2channels
AT canojaimezmarife lamberteatonsyndromeigginhibitstransmitterreleaseviapqca2channels
AT langbethan lamberteatonsyndromeigginhibitstransmitterreleaseviapqca2channels
AT vincentangela lamberteatonsyndromeigginhibitstransmitterreleaseviapqca2channels
AT volynskikirille lamberteatonsyndromeigginhibitstransmitterreleaseviapqca2channels
AT kullmanndimitrim lamberteatonsyndromeigginhibitstransmitterreleaseviapqca2channels